The University of Southampton
University of Southampton Institutional Repository

Roles and impacts of pharmacists in attention-deficit hyperactivity disorder services: a scoping review

Roles and impacts of pharmacists in attention-deficit hyperactivity disorder services: a scoping review
Roles and impacts of pharmacists in attention-deficit hyperactivity disorder services: a scoping review
Introduction: demand for attention-deficit hyperactivity disorder (ADHD) services has increased substantially across health systems, placing pressure on specialist services and contributing to prolonged waiting times and inconsistent medication monitoring. Pharmacists have established expertise in medicines optimisation and, in some settings, are authorised to prescribe. Yet their role within ADHD care pathways remains poorly characterised.

Aim: this scoping review aims to map the existing empirical evidence on pharmacist involvement in ADHD services, synthesise reported roles and impacts, and identify key evidence gaps to inform future research and service development.

Method: a scoping review was conducted in accordance with the Arksey and O’Malley framework and reported using PRISMA-ScR guidance. Six databases (PubMed, PsycINFO, Embase, CINAHL, Scopus, and Web of Science) were searched from inception to December 2025. Empirical studies evaluating implemented pharmacist involvement in ADHD services were included, irrespective of study design. Data were charted and synthesised narratively across domains relating to clinical care, service delivery, economic outcomes, and barriers to implementation.

Results: thirteen studies were included, published between 2008 and 2025, primarily from the United States and the United Kingdom. Most were service evaluations or pre-post studies, with one randomised trial. Pharmacists were involved in a broad range of activities, including medication initiation, titration, monitoring, follow-up, patient education, and service governance, often as independent prescribers or within collaborative multidisciplinary models. Reported impacts included improved adherence to recommended monitoring standards, increased service capacity, reduced waiting times, and more efficient workforce utilisation, with some evidence of potential cost savings. However, outcome measures varied widely, and patient-reported outcomes, comparative effectiveness, and implementation processes were inconsistently examined.

Conclusion: this review identifies a small but expanding evidence base indicating potential roles for pharmacists in ADHD services, particularly in medicines management and service delivery. However, the absence of clearly defined service models and limited comparative and implementation-focused evidence constrain wider adoption across health systems. Further research is needed to inform scalable and sustainable approaches to pharmacist integration in ADHD care.
ADHD; Pharmacist; Service delivery; Medicine optimisation; Prescribing, Prescribing, Service delivery, ADHD, Medicine optimisation, Pharmacist
2210-7703
1812-1826
Umair, Muhammad Khan
5a6c40b9-8021-4231-bc72-a6f4fafcc665
Naqvi, Atta Abbas
6dd66558-06ca-467c-baa3-094a24271de6
Wong, Ian Chi-Kei
728c36fe-d189-4d9e-997b-d8276ad888a6
Maidment, Ian
0dfe2ce8-2a52-4937-a700-abe364f199da
Brown, Graham
c80dcdc8-03ef-439f-bc20-3fa9272827a5
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Umair, Muhammad Khan
5a6c40b9-8021-4231-bc72-a6f4fafcc665
Naqvi, Atta Abbas
6dd66558-06ca-467c-baa3-094a24271de6
Wong, Ian Chi-Kei
728c36fe-d189-4d9e-997b-d8276ad888a6
Maidment, Ian
0dfe2ce8-2a52-4937-a700-abe364f199da
Brown, Graham
c80dcdc8-03ef-439f-bc20-3fa9272827a5
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb

Umair, Muhammad Khan, Naqvi, Atta Abbas, Wong, Ian Chi-Kei, Maidment, Ian, Brown, Graham and Cortese, Samuele (2026) Roles and impacts of pharmacists in attention-deficit hyperactivity disorder services: a scoping review. International journal of clinical pharmacy, 48 (5), 1812-1826. (doi:10.1007/s11096-026-02184-2).

Record type: Article

Abstract

Introduction: demand for attention-deficit hyperactivity disorder (ADHD) services has increased substantially across health systems, placing pressure on specialist services and contributing to prolonged waiting times and inconsistent medication monitoring. Pharmacists have established expertise in medicines optimisation and, in some settings, are authorised to prescribe. Yet their role within ADHD care pathways remains poorly characterised.

Aim: this scoping review aims to map the existing empirical evidence on pharmacist involvement in ADHD services, synthesise reported roles and impacts, and identify key evidence gaps to inform future research and service development.

Method: a scoping review was conducted in accordance with the Arksey and O’Malley framework and reported using PRISMA-ScR guidance. Six databases (PubMed, PsycINFO, Embase, CINAHL, Scopus, and Web of Science) were searched from inception to December 2025. Empirical studies evaluating implemented pharmacist involvement in ADHD services were included, irrespective of study design. Data were charted and synthesised narratively across domains relating to clinical care, service delivery, economic outcomes, and barriers to implementation.

Results: thirteen studies were included, published between 2008 and 2025, primarily from the United States and the United Kingdom. Most were service evaluations or pre-post studies, with one randomised trial. Pharmacists were involved in a broad range of activities, including medication initiation, titration, monitoring, follow-up, patient education, and service governance, often as independent prescribers or within collaborative multidisciplinary models. Reported impacts included improved adherence to recommended monitoring standards, increased service capacity, reduced waiting times, and more efficient workforce utilisation, with some evidence of potential cost savings. However, outcome measures varied widely, and patient-reported outcomes, comparative effectiveness, and implementation processes were inconsistently examined.

Conclusion: this review identifies a small but expanding evidence base indicating potential roles for pharmacists in ADHD services, particularly in medicines management and service delivery. However, the absence of clearly defined service models and limited comparative and implementation-focused evidence constrain wider adoption across health systems. Further research is needed to inform scalable and sustainable approaches to pharmacist integration in ADHD care.

Text
Revised manuscript - Clean
Restricted to Repository staff only
Request a copy

More information

Accepted/In Press date: 12 June 2026
e-pub ahead of print date: 15 July 2026
Published date: October 2026
Keywords: ADHD; Pharmacist; Service delivery; Medicine optimisation; Prescribing, Prescribing, Service delivery, ADHD, Medicine optimisation, Pharmacist

Identifiers

Local EPrints ID: 515046
URI: https://eprints.soton.ac.uk/id/eprint/515046
ISSN: 2210-7703
PURE UUID: fe53b9b2-e882-4bc1-9b5d-9051687d1c47
ORCID for Samuele Cortese: ORCID iD orcid.org/0000-0001-5877-8075

Catalogue record

Date deposited: 05 Oct 2026 16:26
Last modified: 06 Oct 2026 02:04

Export record

Altmetrics

Contributors

Author: Muhammad Khan Umair
Author: Atta Abbas Naqvi
Author: Ian Chi-Kei Wong
Author: Ian Maidment
Author: Graham Brown
Author: Samuele Cortese ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×